Synereca Pharmaceuticals, Inc. — Form D
Synereca Pharmaceuticals, Inc. of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-15. The offering totals $1.2M, of which $600K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-08-15
- Form: D
- Accession: 0001487939-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $600K
- Remaining: $600K
- Investors: 10
- Date of first sale: 2017-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-292834
Issuer
- Name: Synereca Pharmaceuticals, Inc.
- CIK: 0001487939
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 865 RESEARCH PARKWAY, OKLAHOMA CITY, OK, 73104
- Phone: 405-319-8165
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Mark I Corrigan | Director | Oklahoma City, OK |
| Clayton I Duncan | Director | Oklahoma City, OK |
| Bennett W Love | Director | Oklahoma City, OK |
| Scott I Meacham | Director | Oklahoma City, OK |
| Scott F Singleton | Director | Oklahoma City, OK |
| Clayton I Duncan | Executive Officer | Oklahoma City, OK |
| Richard E Gammans | Executive Officer | Oklahoma City, OK |
| Richard E Gammans | Promoter | Oklahoma City, OK |
| Scott Singleton | Director | HOUSTON, TX |
| Scott Singleton | Executive Officer | HOUSTON, TX |
| W Bennett Love | Director | Chapel Hill, NC |
| W Bennett Love | Executive Officer | Chapel Hill, NC |
| Richard W Reichow | Executive Officer | Chapel Hill, NC |
Other filings by this issuer (1)
More